ES2188592T3 - Adn que codifica para la kappa-caseina, proceso para la obtencion de la proteina y uso de la misma. - Google Patents

Adn que codifica para la kappa-caseina, proceso para la obtencion de la proteina y uso de la misma.

Info

Publication number
ES2188592T3
ES2188592T3 ES93902110T ES93902110T ES2188592T3 ES 2188592 T3 ES2188592 T3 ES 2188592T3 ES 93902110 T ES93902110 T ES 93902110T ES 93902110 T ES93902110 T ES 93902110T ES 2188592 T3 ES2188592 T3 ES 2188592T3
Authority
ES
Spain
Prior art keywords
mammer
human
dna sequence
sequence
expression system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902110T
Other languages
English (en)
Inventor
Lennart Hansson
Mats Stromqvist
Sven Bergstrom
Olle Hernell
Jan Tornell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symbicom AB
Original Assignee
Symbicom AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbicom AB filed Critical Symbicom AB
Application granted granted Critical
Publication of ES2188592T3 publication Critical patent/ES2188592T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/101—Bovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

LA INVENCION PRESENTE SE REFIERE A UN SISTEMA DE EXPRESION CON UNA SECUENCIA DE ADN QUE CODIFICA UN POLIPEPTIDO CON ACTIVIDAD BIOLOGICA DE K-CASEINA HUMANA, COMPRENDIENDO EL SISTEMA UNA SECUENCIA DE FLANQUEO DE 5'' CAPAZ DE MEDIATIZAR LA EXPRESION DE DICHA SECUENCIA DE ADN. EN SU ENCARNACION PREFERIDA LA SECUENCIA DE FLANQUEO PROCEDE DE UN GEN DE PROTEINA DE LECHE DE MAMIFERO COMO EL GEN DE CASEINA O EL GEN DE PROTEINA ACIDA DE SUERO (WAP) Y LA SECUENCIA DE ADN CONTIENE AL MENOS UNA SECUENCIA DE NITRON. EL INVENTO SE RELACIONA TAMBIEN CON SECUENCIAS DE ADN, VECTORES DE EXPRESION REPLICABLES Y CELULAS QUE HOSPEDAN A LOS MENCIONADOS VECTORES, POLIPEPTIDOS RECOMBINADOS POR EJ. EN FORMA GLICOSILATADA, Y LECHE, FORMULA INFANTIL O SUPLEMENTO NUTRITIVO CON POLIPEPTIDOS RECOMBINADOS. LA INVENCION TAMBIEN SE REFIERE A UN METODO PARA PRODUCIR UN MAMIFERO TRANSGENICO NO-HUMANO, QUE COMPRENDE LA INYECCION DE UN SISTEMA DE EXPRESION COMO EL DEFINIDO PRECEDENTEMENTE Y OPCIONALMENTE MAS ADN CODIFICADOR DEBETA-CASEINA O ANALOGO, VARIANTE O SUBSECUENCIA EN UN HUEVO FERTILIZADO O UNA CELULA DE UN EMBRION DE MAMIFERO DE FORMA QUE SE INCORPORE EL SISTEMA DE EXPRESION EN LA LINEA GERMINAL DEL MAMIFERO Y EL DESARROLLO DEL RESULTANTE HUEVO FERTILIZADO O EMBRION INYECTADO EN UN MAMIFERO HEMBRA ADULTO. EN UNA OPCION, EL POLIPEPTIDO ENDOGENO QUE EXPRESA LA CAPACIDAD DEL MAMIFERO SE DESTRUYE Y/O SE REEMPLAZA CON EL SISTEMA DE EXPRESION DEFINIDO ANTERIORMENTE. EL INVENTO ADEMAS SE REFIERE A UN MAMIFERO TRANSGENICO NO-HUMANO COMO RATON, RATA, CONEJO, CABRA, OVEJA, CERDO, LLAMA, CAMELLO O ESPECIES BOVINAS CUYAS CELULAS GERMINALES Y CELULAS SOMATICAS CONTIENEN UNA SECUENCIA DE ADN COMO LA DEFINIDA PRECEDENTEMENTE COMO RESULTADO DE LA INCORPORACION CROMOSOMICA EN EL GENOMA DE MAMIFERO NO-HUMANO O EN EL GENOMA DE UN ANTEPASADO DE DICHO MAMIFERO NO-HUMANO.
ES93902110T 1992-01-23 1993-01-25 Adn que codifica para la kappa-caseina, proceso para la obtencion de la proteina y uso de la misma. Expired - Lifetime ES2188592T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK9288A DK8892D0 (da) 1992-01-23 1992-01-23 Humant proteingen

Publications (1)

Publication Number Publication Date
ES2188592T3 true ES2188592T3 (es) 2003-07-01

Family

ID=8089602

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902110T Expired - Lifetime ES2188592T3 (es) 1992-01-23 1993-01-25 Adn que codifica para la kappa-caseina, proceso para la obtencion de la proteina y uso de la misma.

Country Status (11)

Country Link
US (2) US6222094B1 (es)
EP (1) EP0625197B1 (es)
JP (1) JP3467272B2 (es)
AT (1) ATE229071T1 (es)
AU (1) AU3346493A (es)
CA (1) CA2128110A1 (es)
DE (1) DE69332537T2 (es)
DK (2) DK8892D0 (es)
ES (1) ES2188592T3 (es)
PT (1) PT625197E (es)
WO (1) WO1993015196A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
EP0652889A4 (en) * 1992-06-15 1997-05-07 Gene Pharming Europ Bv PRODUCTION OF RECOMBINANT POLYPEPTIDES BY BOVINE SPECIES AND TRANSGENIC PROCESSES.
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
WO1995024494A1 (en) * 1994-03-09 1995-09-14 Abbott Laboratories Humanized milk
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
CA2184688A1 (en) * 1994-03-09 1995-09-14 Pedro Antonio Prieto Transgenic animals producing oligosaccharides and glycoconjugates
US5712250A (en) * 1994-09-16 1998-01-27 Abbott Laboratories Product for inhibition of human rotavirus infection
EP0784479A1 (en) * 1994-09-16 1997-07-23 Abbott Laboratories Inhibition of human rotavirus infection
US5576300A (en) * 1994-09-16 1996-11-19 Abbott Laboratories Method for inhibition of human rotavirus infection
US6455280B1 (en) 1998-12-22 2002-09-24 Genset S.A. Methods and compositions for inhibiting neoplastic cell growth
US6514825B1 (en) * 2000-06-28 2003-02-04 Conexant Systems, Inc. Technique for reducing 1/f noise in MOSFETs
EP2292273A3 (en) 2001-10-10 2011-11-23 BioGeneriX AG Remodeling and glycoconjugation of peptides
JP4549848B2 (ja) * 2002-05-24 2010-09-22 エイツー・コーポレーション・リミテッド 動物の遺伝子型を決定する方法
US7011949B2 (en) * 2002-09-30 2006-03-14 Agilent Technologies, Inc. Methods and compositions for producing labeled probe nucleic acids for use in array based comparative genomic hybridization applications
US7982008B2 (en) 2002-11-27 2011-07-19 David Bar-Or Treatment of diseases and conditions mediated by increased phosphorylation
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2005081904A2 (en) 2004-02-20 2005-09-09 The Burnham Institute Antimicrobial carbohydrates and methods of using same
US7968762B2 (en) * 2004-07-13 2011-06-28 Van Andel Research Institute Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
AU2006217901B2 (en) * 2005-02-24 2011-09-29 Dsm Ip Assets B.V. Blood pressure lowering peptides from glycomacropeptide
WO2007035870A2 (en) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
WO2010119088A2 (en) * 2009-04-15 2010-10-21 Bodo Melnik Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity
US20140163229A1 (en) * 2011-04-07 2014-06-12 Cornell University Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same
FI2764565T3 (fi) 2011-10-05 2023-04-24 Oned Mat Inc Piin nanorakenteen aktiivimateriaaleja litiumioniakkuihin ja niihin liittyviä prosesseja, koostumuksia, komponentteja ja laitteita
EA023387B1 (ru) * 2012-10-08 2016-05-31 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pFK3, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ПЕПТИДА RL3, ЯВЛЯЮЩЕГОСЯ АНАЛОГОМ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, РЕКОМБИНАНТНЫЙ ШТАММ БАКТЕРИЙ ESCHERICHIA COLI XL1-Blue/pFK3 И РЕКОМБИНАНТНЫЙ ПЕПТИД RL3 - АНАЛОГ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, ОБЛАДАЮЩИЙ АПОПТОТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К РАКОВЫМ КЛЕТКАМ
EA023475B1 (ru) * 2012-10-08 2016-06-30 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pFK4, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ПЕПТИДА RL4, ЯВЛЯЮЩЕГОСЯ АНАЛОГОМ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, РЕКОМБИНАНТНЫЙ ШТАММ БАКТЕРИЙ ESCHERICHIA COLI XL1-BLUE/pFK4 И РЕКОМБИНАНТНЫЙ ПЕПТИД RL4 - АНАЛОГ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, ОБЛАДАЮЩИЙ АПОПТОТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К РАКОВЫМ КЛЕТКАМ
CN113841738A (zh) 2014-08-21 2021-12-28 完美日公司 包含酪蛋白的组合物及其生产方法
JP7643829B2 (ja) 2016-08-25 2025-03-11 パーフェクト・デイ・インコーポレイテッド 乳タンパク質及び非動物性タンパク質を含む食品、並びにその生産方法
EP3962289A4 (en) * 2019-05-02 2023-04-12 New Culture Inc. CHEESE- AND YOGURT-LIKE COMPOSITIONS AND RELATED PROCESSES
CA3196018A1 (en) 2020-09-18 2022-03-24 Standing Ovation Method for producing cheese substitutes
EP3970501A1 (en) 2020-09-18 2022-03-23 Baio Method for producing cheese substitutes
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
WO2022072718A1 (en) 2020-09-30 2022-04-07 Nobell Foods, Inc. Recombinant milk proteins and food compositions comprising the same
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
US11771105B2 (en) 2021-08-17 2023-10-03 New Culture Inc. Dairy-like compositions and related methods
WO2023197003A2 (en) * 2022-04-08 2023-10-12 Mozza Foods, Inc. Making cheese with soy proteins
CN115851468A (zh) * 2022-07-18 2023-03-28 江南大学 一种生产人酪蛋白巨肽的重组毕赤酵母及其应用
EP4328240A1 (en) * 2022-08-25 2024-02-28 Real Deal Milk S.L. Recombinant protein production
US20260193634A1 (en) * 2022-11-10 2026-07-09 The Johns Hopkins University System For Modulating Receptor Tyrosine Kinase Signaling And Methods Of Use Thereof
IL328532A (en) 2023-11-27 2026-07-01 Standing Ovation Method for improving the texture of a milk replacer product
IL328637A (en) 2023-11-27 2026-07-01 Standing Ovation Method for improving the foaming properties of a liquid milk replacer product
EP4573922A1 (en) 2023-12-18 2025-06-25 Standing Ovation Method for preparing an aerated frozen product

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0081570A4 (en) 1981-06-12 1985-09-02 Univ Ohio GENETIC TRANSFORMATION OF ZYGOTS.
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
EP0181634A3 (en) * 1984-11-14 1987-09-09 Takeda Chemical Industries, Ltd. Synthetic gene for human lysozyme
DE3751873T2 (de) * 1986-04-09 1997-02-13 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
DE3752347T2 (de) 1986-05-20 2002-09-26 The General Hospital Corp., Boston Verfahren zur pharmakokinetischen Studie der Insulin-Expression mit nicht-menschlichem Transgen-Säugetier
GB8615942D0 (en) 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
AU7879987A (en) 1986-08-28 1988-03-24 Immunex Corp. Expression of heterologous proteins by transgenic lactating mammals
EP0279582A3 (en) * 1987-02-17 1989-10-18 Pharming B.V. Dna sequences to target proteins to the mammary gland for efficient secretion
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
WO1991003551A1 (en) 1989-09-11 1991-03-21 Tsi-Mason Research Institute Production of growth hormone in transgenic animal milk
DE69027683T2 (de) 1989-12-01 1997-02-13 Pharming Bv Herstellung rekombinanter polypeptide durch rinder und transgene methoden
US5795611A (en) 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
US5391497A (en) 1992-10-13 1995-02-21 University Of Colorado Foundation, Inc. Human k-casein

Also Published As

Publication number Publication date
DE69332537D1 (de) 2003-01-16
US6222094B1 (en) 2001-04-24
PT625197E (pt) 2003-04-30
ATE229071T1 (de) 2002-12-15
DE69332537T2 (de) 2003-09-04
EP0625197A1 (en) 1994-11-23
DK0625197T3 (da) 2003-03-24
WO1993015196A1 (en) 1993-08-05
CA2128110A1 (en) 1993-08-05
JP3467272B2 (ja) 2003-11-17
AU3346493A (en) 1993-09-01
EP0625197B1 (en) 2002-12-04
JPH07503136A (ja) 1995-04-06
DK8892D0 (da) 1992-01-23
US6232094B1 (en) 2001-05-15

Similar Documents

Publication Publication Date Title
PT625197E (pt) Adn que codifica a k-cseina, processo para a obtencao da proteina e sua utilizacao
Soreq et al. The biosynthesis of biologically active proteins in mRNA-microinjected xenopus oocyte
Watson The cell biology of blastocyst development
De Robertis et al. Gene activation in somatic nuclei after injection into amphibian oocytes.
Ebert et al. Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: generation of transgenic goats and analysis of expression
Dice Peptide sequences that target cytosolic proteins for lysosomal proteolysis
Lowry et al. The evolution of vertebrate corticotrophin and melanocyte stimulating hormone
CN1813642B (zh) 作为细胞核转移胞质体受体的未激活卵母细胞
Flach et al. The transition from maternal to embryonic control in the 2‐cell mouse embryo.
Calvin et al. A developmental study of rat sperm and testis selenoproteins
ES8500325A1 (es) Procedimiento para la preparacion de proteinas funcionales de uroquinasa humana.
AR016537A1 (es) Una celula humana para la fabricacion de eritropoyetina por activacion genica endogena, un procedimiento para la fabricacion de la misma y una construccionde adn a ser usada en el mismo, un procedimiento para la fabricacion de epo humana, epo humana aislada obtenida por el mismo y un preparado farma
Pratt et al. The legacy from the oocyte and its role in controlling early development of the mouse embryo
WO2005033274A3 (en) A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
JPS6420095A (en) Polypeptide having anti-blood coagulating action
CN1254379A (zh) 通过使用融合蛋白生产酰胺化肽的方法
ATE253639T1 (de) Verfahren zur herstellung von peptiden
IT1228210B (it) Procedimento per la introduzione di dna esogeno nelle cellule somatiche e germinali di animali.
Asselbergs Post-synthetic fate of the translation products of messenger RNA microinjected into Xenopus oocytes
Petzoldt et al. Spontaneous parthenogenesis in Mus musculus: comparison of protein synthesis in parthenogenetic and normal preimplantation embryos
Kurabuchi et al. Immunocytochemical localization of prohormone convertases PC1 and PC2 in the anuran pituitary gland: subcellular localization in corticotrope and melanotrope cells
ES8405842A1 (es) Procedimiento de producir razas estables de celulas de mamiferos
US5206160A (en) Composition containing buf-3 and superoxide dismutase as a cell cleavage promoting agent
Fazleabas et al. Steroid-induced proteins of the primate oviduct and uterus: potential regulators of reproductive function
Day et al. Polymorphism of canine serum albumin